219 related articles for article (PubMed ID: 21285398)
21. A mutation associated with CMT2A neuropathy causes defects in Fzo1 GTP hydrolysis, ubiquitylation, and protein turnover.
Amiott EA; Cohen MM; Saint-Georges Y; Weissman AM; Shaw JM
Mol Biol Cell; 2009 Dec; 20(23):5026-35. PubMed ID: 19812251
[TBL] [Abstract][Full Text] [Related]
22. A French family with Charcot-Marie-Tooth disease related to simultaneous heterozygous MFN2 and GDAP1 mutations.
Vital A; Latour P; Sole G; Ferrer X; Rouanet M; Tison F; Vital C; Goizet C
Neuromuscul Disord; 2012 Aug; 22(8):735-41. PubMed ID: 22546700
[TBL] [Abstract][Full Text] [Related]
23. [Mutations in the mitofusin 2 gene are the most common cause of Charcot-Marie-Tooth type 2 disease].
Sołtysińska E; Kabzińska D; Kochański A
Neurol Neurochir Pol; 2007; 41(4):350-4. PubMed ID: 17874344
[TBL] [Abstract][Full Text] [Related]
24. A cohort study of MFN2 mutations and phenotypic spectrums in Charcot-Marie-Tooth disease 2A patients.
Choi BO; Nakhro K; Park HJ; Hyun YS; Lee JH; Kanwal S; Jung SC; Chung KW
Clin Genet; 2015 Jun; 87(6):594-8. PubMed ID: 24863639
[TBL] [Abstract][Full Text] [Related]
25. A cohort study of Han Chinese MFN2-related Charcot-Marie-Tooth 2A.
Lv H; Wang L; Zhang W; Wang Z; Zuo Y; Liu J; Yuan Y
J Neurol Sci; 2015 Nov; 358(1-2):153-7. PubMed ID: 26382835
[TBL] [Abstract][Full Text] [Related]
26. Restoring mitofusin balance prevents axonal degeneration in a Charcot-Marie-Tooth type 2A model.
Zhou Y; Carmona S; Muhammad AKMG; Bell S; Landeros J; Vazquez M; Ho R; Franco A; Lu B; Dorn GW; Wang S; Lutz CM; Baloh RH
J Clin Invest; 2019 Mar; 129(4):1756-1771. PubMed ID: 30882371
[TBL] [Abstract][Full Text] [Related]
27. A human mitofusin 2 mutation can cause mitophagic cardiomyopathy.
Franco A; Li J; Kelly DP; Hershberger RE; Marian AJ; Lewis RM; Song M; Dang X; Schmidt AD; Mathyer ME; Edwards JR; Strong CG; Dorn GW
Elife; 2023 Nov; 12():. PubMed ID: 37910431
[TBL] [Abstract][Full Text] [Related]
28. The MFN2 gene is responsible for mitochondrial DNA instability and optic atrophy 'plus' phenotype.
Rouzier C; Bannwarth S; Chaussenot A; Chevrollier A; Verschueren A; Bonello-Palot N; Fragaki K; Cano A; Pouget J; Pellissier JF; Procaccio V; Chabrol B; Paquis-Flucklinger V
Brain; 2012 Jan; 135(Pt 1):23-34. PubMed ID: 22189565
[TBL] [Abstract][Full Text] [Related]
29. Clinical and electrophysiologic features of CMT2A with mutations in the mitofusin 2 gene.
Lawson VH; Graham BV; Flanigan KM
Neurology; 2005 Jul; 65(2):197-204. PubMed ID: 16043786
[TBL] [Abstract][Full Text] [Related]
30. Charcot-Marie-Tooth type 2A in vivo models: Current updates.
Abati E; Rizzuti M; Anastasia A; Comi GP; Corti S; Rizzo F
J Cell Mol Med; 2024 May; 28(9):e18293. PubMed ID: 38722298
[TBL] [Abstract][Full Text] [Related]
31. Charcot-Marie-Tooth disease type 2A: from typical to rare phenotypic and genotypic features.
Bombelli F; Stojkovic T; Dubourg O; Echaniz-Laguna A; Tardieu S; Larcher K; Amati-Bonneau P; Latour P; Vignal O; Cazeneuve C; Brice A; Leguern E
JAMA Neurol; 2014 Aug; 71(8):1036-42. PubMed ID: 24957169
[TBL] [Abstract][Full Text] [Related]
32. MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A.
Rocha AG; Franco A; Krezel AM; Rumsey JM; Alberti JM; Knight WC; Biris N; Zacharioudakis E; Janetka JW; Baloh RH; Kitsis RN; Mochly-Rosen D; Townsend RR; Gavathiotis E; Dorn GW
Science; 2018 Apr; 360(6386):336-341. PubMed ID: 29674596
[TBL] [Abstract][Full Text] [Related]
33. MFN2 mutations in Charcot-Marie-Tooth disease alter mitochondria-associated ER membrane function but do not impair bioenergetics.
Larrea D; Pera M; Gonnelli A; Quintana-Cabrera R; Akman HO; Guardia-Laguarta C; Velasco KR; Area-Gomez E; Dal Bello F; De Stefani D; Horvath R; Shy ME; Schon EA; Giacomello M
Hum Mol Genet; 2019 Jun; 28(11):1782-1800. PubMed ID: 30649465
[TBL] [Abstract][Full Text] [Related]
34. Clinical, electrophysiological and pathological findings of a patient with CMT2 due to the p.Ala738Val mitofusin 2 mutation.
Luigetti M; Fabrizi GM; Taioli F; Conte A; Del Grande A; Sabatelli M
J Neurol Sci; 2011 Aug; 307(1-2):168-70. PubMed ID: 21601224
[TBL] [Abstract][Full Text] [Related]
35. Novel mitofusin 2 splice-site mutation causes Charcot-Marie-Tooth disease type 2 with prominent sensory dysfunction.
Martikainen MH; Kytövuori L; Majamaa K
Neuromuscul Disord; 2014 Apr; 24(4):360-4. PubMed ID: 24530046
[TBL] [Abstract][Full Text] [Related]
36. MITOL-mediated DRP1 ubiquitylation and degradation promotes mitochondrial hyperfusion in a CMT2A-linked MFN2 mutant.
Das R; Kamal IM; Das S; Chakrabarti S; Chakrabarti O
J Cell Sci; 2022 Jan; 135(2):. PubMed ID: 34870686
[TBL] [Abstract][Full Text] [Related]
37. Increased mitochondrial fusion in a autosomal recessive CMT2A family with mitochondrial GTPase mitofusin 2 mutations.
Codron P; Chevrollier A; Kane MS; Echaniz-Laguna A; Latour P; Reynier P; Bonneau D; Verny C; Procaccio V; Lenaers G; Cassereau J
J Peripher Nerv Syst; 2016 Dec; 21(4):365-369. PubMed ID: 27706887
[TBL] [Abstract][Full Text] [Related]
38. Genotype-phenotype correlations in Charcot-Marie-Tooth disease type 2 caused by mitofusin 2 mutations.
Calvo J; Funalot B; Ouvrier RA; Lazaro L; Toutain A; De Mas P; Bouche P; Gilbert-Dussardier B; Arne-Bes MC; Carrière JP; Journel H; Minot-Myhie MC; Guillou C; Ghorab K; Magy L; Sturtz F; Vallat JM; Magdelaine C
Arch Neurol; 2009 Dec; 66(12):1511-6. PubMed ID: 20008656
[TBL] [Abstract][Full Text] [Related]
39. Characterizing the phenotypic manifestations of MFN2 R104W mutation in Charcot-Marie-Tooth type 2.
Genari AB; Borghetti VH; Gouvêa SP; Bueno KC; dos Santos PL; dos Santos AC; Barreira AA; Lourenço CM; Marques W
Neuromuscul Disord; 2011 Jun; 21(6):428-32. PubMed ID: 21531138
[TBL] [Abstract][Full Text] [Related]
40. Mitofusin 1 overexpression rescues the abnormal mitochondrial dynamics caused by the Mitofusin 2 K357T mutation in vitro.
Stavropoulos F; Georgiou E; Schiza N; Bell S; Baloh RH; Kleopa KA; Sargiannidou I
J Peripher Nerv Syst; 2023 Sep; 28(3):329-340. PubMed ID: 37220142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
